Senior insider sale
EVP, Chief Scientific Officer at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$2.13M
4.48K shares
What this filing means
BUNNAGE MARK E. plans to sell 4.48K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $2.13M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/17/2026ACC: 0001959173-26-001066
Officer· EVP, Chief Scientific Officer
Since Feb 2026
4.48K
Shares to sell
$2.13M
Approx. market value
2.44K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/13/2026
2.44KTotal acquired2.44K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/13/2026 | Restricted Stock Vesting Compensation | 2.44K | — |
| Total | 2.44K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
2.02K
Market value
$930.5K
2/11/2026
—Completed
Units to sell
23.00
Market value
$10.6K
12/29/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.44K
Market value
$1.19M
2/17/2026
Total
Units
4.48K
Value
$2.13M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/11/2026 | 2.02K | $930.5K | — | Completed |
12/29/2025 | 23.00 | $10.6K | — | Completed |
| Planned — Approximate Date | ||||
2/17/2026 | 2.44K | $1.19M | NASDAQ | Planned |
| Total | 4.48K | $2.13M | ||